Giant Prepyloric Ulcer Haemorrhage: Patient Characteristics, Treatment, and Outcome in 2003–2012

Table 1

Patients’ characteristics for giant peptic ulcer haemorrhage: group I (study group): giant prepyloric ulcer haemorrhage; group II: giant gastric ulcer haemorrhage; group III: giant duodenal ulcer haemorrhage.

Characteristics	Group I	Group II	Group III
	Patients (%)	Patients (%)	Patients (%)
Giant ulcer (diameter ≥ 2 cm)	24	115	92
Sex
Female	11 (45.8)	38 (33.0)	31 (33.7)
Male	13 (54.2)	77 (67.0)	61 (66.3)
Mean age (yrs ± SD)	68.9±11.7	64.0±14.2	66.4±14.0
Female	77.1±5.1	74.2±11.5	73.9±10.7
Male	62.0±11.3	59.0±12.7	74.0±10.5
Age ≥ 65 yrs	16 (66.7)*	50 (43.5)	56 (60.9)
Female	11/16 (68.8)	28/50 (56.0)	28/56 (50.0)
Male	5/16 (31.2)	22/50 (44.0)	28/56 (50.0)
Previous hospitalisation due to PUH	7 (29.2)	22 (19.1)	19 (20.6)
Drug use	18 (75.0)	71 (61.7)	64 (69.6)
Female	9/11 (81.8)	26/38 (68.4)	23/31 (74.2)
Male	9/13 (69.2)	45/77 (58.4)	41/61 (67.2)
Forrest I-II cases	17 (70.8)	94 (81.7)	70 (76.1)

Drug use: potentially associated with poor outcome of haemorrhage; PUH: peptic ulcer haemorrhage; Forrest I-II = I: spurting or oozing bleeding; II: visible vessel or adherent clot; ∗significant difference between group I and group II.